

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 5.16549657 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.28992858 |
| 3 | mitotic metaphase plate congression (GO:0007080) | 4.13344840 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.98563798 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.98563798 |
| 6 | metaphase plate congression (GO:0051310) | 3.93431729 |
| 7 | definitive hemopoiesis (GO:0060216) | 3.89675005 |
| 8 | ribosome assembly (GO:0042255) | 3.85010896 |
| 9 | DNA double-strand break processing (GO:0000729) | 3.84272914 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.82461345 |
| 11 | sister chromatid segregation (GO:0000819) | 3.81239566 |
| 12 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.78735996 |
| 13 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.78735996 |
| 14 | mitotic spindle checkpoint (GO:0071174) | 3.74356991 |
| 15 | spindle checkpoint (GO:0031577) | 3.68140546 |
| 16 | mitotic sister chromatid segregation (GO:0000070) | 3.66329144 |
| 17 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.64358414 |
| 18 | negative regulation of sister chromatid segregation (GO:0033046) | 3.64358414 |
| 19 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.64358414 |
| 20 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.64358414 |
| 21 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.64358414 |
| 22 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.62516656 |
| 23 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.61007294 |
| 24 | negative regulation of chromosome segregation (GO:0051985) | 3.58139856 |
| 25 | establishment of integrated proviral latency (GO:0075713) | 3.57304052 |
| 26 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.57193841 |
| 27 | mitotic G2/M transition checkpoint (GO:0044818) | 3.53832258 |
| 28 | mitotic G2 DNA damage checkpoint (GO:0007095) | 3.52978925 |
| 29 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 3.51359282 |
| 30 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 3.51359282 |
| 31 | mitotic spindle assembly checkpoint (GO:0007094) | 3.50686427 |
| 32 | spindle assembly checkpoint (GO:0071173) | 3.48642590 |
| 33 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.45220490 |
| 34 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.45220490 |
| 35 | regulation of mitotic sister chromatid separation (GO:0010965) | 3.43713708 |
| 36 | regulation of mitotic sister chromatid segregation (GO:0033047) | 3.43713708 |
| 37 | regulation of sister chromatid segregation (GO:0033045) | 3.43713708 |
| 38 | signal peptide processing (GO:0006465) | 3.43634362 |
| 39 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 3.39836637 |
| 40 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 3.39836637 |
| 41 | isotype switching (GO:0045190) | 3.39836637 |
| 42 | histone exchange (GO:0043486) | 3.37399564 |
| 43 | establishment of chromosome localization (GO:0051303) | 3.33423049 |
| 44 | kinetochore assembly (GO:0051382) | 3.29838276 |
| 45 | regulation of chromosome segregation (GO:0051983) | 3.29003031 |
| 46 | nuclear pore complex assembly (GO:0051292) | 3.27250509 |
| 47 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.25952548 |
| 48 | cellular response to zinc ion (GO:0071294) | 3.23584821 |
| 49 | nuclear pore organization (GO:0006999) | 3.19677801 |
| 50 | non-recombinational repair (GO:0000726) | 3.17622360 |
| 51 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.17622360 |
| 52 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.11724202 |
| 53 | CENP-A containing nucleosome assembly (GO:0034080) | 3.11306674 |
| 54 | DNA topological change (GO:0006265) | 3.10637324 |
| 55 | transcription from mitochondrial promoter (GO:0006390) | 3.10626724 |
| 56 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.10135557 |
| 57 | positive regulation of B cell differentiation (GO:0045579) | 3.09584672 |
| 58 | proteasome assembly (GO:0043248) | 3.08354783 |
| 59 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.07394691 |
| 60 | hepatocyte apoptotic process (GO:0097284) | 3.05289545 |
| 61 | cotranslational protein targeting to membrane (GO:0006613) | 3.04867517 |
| 62 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.04147534 |
| 63 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.03899101 |
| 64 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.02506812 |
| 65 | mitochondrial RNA metabolic process (GO:0000959) | 3.01793716 |
| 66 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.01307210 |
| 67 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.01307210 |
| 68 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.01307210 |
| 69 | protein targeting to ER (GO:0045047) | 3.00513089 |
| 70 | viral transcription (GO:0019083) | 2.98378972 |
| 71 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.98232936 |
| 72 | purine nucleobase biosynthetic process (GO:0009113) | 2.98043580 |
| 73 | regulation of B cell differentiation (GO:0045577) | 2.97397814 |
| 74 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.97257231 |
| 75 | negative regulation of phagocytosis (GO:0050765) | 2.96374423 |
| 76 | IMP biosynthetic process (GO:0006188) | 2.94358044 |
| 77 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.92243072 |
| 78 | response to interferon-beta (GO:0035456) | 2.91975151 |
| 79 | negative regulation of DNA recombination (GO:0045910) | 2.91470919 |
| 80 | regulation of helicase activity (GO:0051095) | 2.91037938 |
| 81 | mitotic nuclear envelope disassembly (GO:0007077) | 2.91029214 |
| 82 | somatic diversification of immune receptors via germline recombination within a single locus (GO:000 | 2.89633997 |
| 83 | somatic cell DNA recombination (GO:0016444) | 2.89633997 |
| 84 | mitotic recombination (GO:0006312) | 2.89100127 |
| 85 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.87996922 |
| 86 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.87719555 |
| 87 | platelet dense granule organization (GO:0060155) | 2.87529317 |
| 88 | somatic diversification of immune receptors (GO:0002200) | 2.87362920 |
| 89 | formation of translation preinitiation complex (GO:0001731) | 2.86225553 |
| 90 | daunorubicin metabolic process (GO:0044597) | 2.85164638 |
| 91 | polyketide metabolic process (GO:0030638) | 2.85164638 |
| 92 | doxorubicin metabolic process (GO:0044598) | 2.85164638 |
| 93 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.84231049 |
| 94 | protein localization to endoplasmic reticulum (GO:0070972) | 2.83627641 |
| 95 | translational termination (GO:0006415) | 2.82092123 |
| 96 | mitochondrial DNA replication (GO:0006264) | 2.81300061 |
| 97 | intra-S DNA damage checkpoint (GO:0031573) | 2.81120536 |
| 98 | mitotic sister chromatid cohesion (GO:0007064) | 2.80232353 |
| 99 | regulation of sister chromatid cohesion (GO:0007063) | 2.79404966 |
| 100 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.79335032 |
| 101 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.79335032 |
| 102 | chromatin remodeling at centromere (GO:0031055) | 2.78355384 |
| 103 | telomere maintenance via recombination (GO:0000722) | 2.78245376 |
| 104 | regulation of mitotic spindle organization (GO:0060236) | 2.78137881 |
| 105 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.77173070 |
| 106 | COPI coating of Golgi vesicle (GO:0048205) | 2.75615912 |
| 107 | Golgi transport vesicle coating (GO:0048200) | 2.75615912 |
| 108 | termination of RNA polymerase II transcription (GO:0006369) | 2.75331572 |
| 109 | histone mRNA metabolic process (GO:0008334) | 2.74304811 |
| 110 | chromosome segregation (GO:0007059) | 2.72708337 |
| 111 | somatic recombination of immunoglobulin gene segments (GO:0016447) | 2.72395660 |
| 112 | somatic diversification of immunoglobulins (GO:0016445) | 2.71240130 |
| 113 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.70450813 |
| 114 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435) | 2.69733200 |
| 115 | megakaryocyte development (GO:0035855) | 2.68824340 |
| 116 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.68613665 |
| 117 | negative regulation of ligase activity (GO:0051352) | 2.68613665 |
| 118 | negative regulation of mRNA processing (GO:0050686) | 2.67673689 |
| 119 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.67038652 |
| 120 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.66811241 |
| 121 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.66473495 |
| 122 | mismatch repair (GO:0006298) | 2.66100861 |
| 123 | translational elongation (GO:0006414) | 2.61792179 |
| 124 | DNA ligation (GO:0006266) | 2.58458767 |
| 125 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.55829687 |
| 126 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.53681456 |
| 127 | DNA strand elongation (GO:0022616) | 2.53602392 |
| 128 | cellular response to interferon-beta (GO:0035458) | 2.53237878 |
| 129 | DNA unwinding involved in DNA replication (GO:0006268) | 2.53129474 |
| 130 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.51201625 |
| 131 | DNA replication-independent nucleosome organization (GO:0034724) | 2.51201625 |
| 132 | regulation of gamma-delta T cell activation (GO:0046643) | 2.47773794 |
| 133 | secretory granule organization (GO:0033363) | 2.45693452 |
| 134 | kinetochore organization (GO:0051383) | 2.40549958 |
| 135 | valine metabolic process (GO:0006573) | 2.39750398 |
| 136 | T cell homeostasis (GO:0043029) | 2.39437230 |
| 137 | necroptotic process (GO:0070266) | 2.36776693 |
| 138 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.36064504 |
| 139 | lymphoid progenitor cell differentiation (GO:0002320) | 2.35050202 |
| 140 | B cell receptor signaling pathway (GO:0050853) | 2.34918168 |
| 141 | dendritic cell chemotaxis (GO:0002407) | 2.31400373 |
| 142 | myeloid dendritic cell activation (GO:0001773) | 2.30584320 |
| 143 | viral life cycle (GO:0019058) | 2.29505228 |
| 144 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.22679898 |
| 145 | negative T cell selection (GO:0043383) | 2.22226537 |
| 146 | regulation of spindle organization (GO:0090224) | 2.21168597 |
| 147 | telomere maintenance via telomere lengthening (GO:0010833) | 2.20746010 |
| 148 | negative thymic T cell selection (GO:0045060) | 2.17138246 |
| 149 | leukocyte homeostasis (GO:0001776) | 2.16257371 |
| 150 | telomere organization (GO:0032200) | 2.15267790 |
| 151 | maturation of SSU-rRNA (GO:0030490) | 2.14392304 |
| 152 | ribosomal small subunit biogenesis (GO:0042274) | 2.14341735 |
| 153 | telomere maintenance (GO:0000723) | 2.14034053 |
| 154 | V(D)J recombination (GO:0033151) | 2.13834950 |
| 155 | * nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.12601292 |
| 156 | lymphocyte homeostasis (GO:0002260) | 2.12365961 |
| 157 | meiotic chromosome segregation (GO:0045132) | 2.12042000 |
| 158 | protein localization to kinetochore (GO:0034501) | 2.11310253 |
| 159 | protein localization to chromosome, centromeric region (GO:0071459) | 2.11073698 |
| 160 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.10477903 |
| 161 | regulation of necroptotic process (GO:0060544) | 2.10346619 |
| 162 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.10157052 |
| 163 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.07937910 |
| 164 | T cell differentiation in thymus (GO:0033077) | 2.07467816 |
| 165 | positive regulation of interferon-alpha production (GO:0032727) | 2.07026097 |
| 166 | dendritic cell migration (GO:0036336) | 2.05670176 |
| 167 | embryonic hemopoiesis (GO:0035162) | 2.05192265 |
| 168 | positive regulation of T cell chemotaxis (GO:0010820) | 2.05167476 |
| 169 | regulation of T cell chemotaxis (GO:0010819) | 2.05167476 |
| 170 | translesion synthesis (GO:0019985) | 2.03382195 |
| 171 | NIK/NF-kappaB signaling (GO:0038061) | 2.03259165 |
| 172 | histamine secretion (GO:0001821) | 2.03055930 |
| 173 | lymph node development (GO:0048535) | 2.02618798 |
| 174 | * nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.01657342 |
| 175 | response to interferon-alpha (GO:0035455) | 2.01283081 |
| 176 | angiogenesis involved in wound healing (GO:0060055) | 2.00523493 |
| 177 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.00465996 |
| 178 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 1.99458500 |
| 179 | cell differentiation involved in metanephros development (GO:0072202) | 1.99098840 |
| 180 | I-kappaB kinase/NF-kappaB signaling (GO:0007249) | 1.98771153 |
| 181 | regulation of B cell apoptotic process (GO:0002902) | 1.98641276 |
| 182 | response to type I interferon (GO:0034340) | 1.98226855 |
| 183 | production of molecular mediator involved in inflammatory response (GO:0002532) | 1.98223629 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.96544200 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.36604631 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.24826105 |
| 4 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.21753695 |
| 5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.16240555 |
| 6 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.99000392 |
| 7 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.91613890 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.66179214 |
| 9 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.64526511 |
| 10 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.57067588 |
| 11 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.50828159 |
| 12 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.49695234 |
| 13 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.44022076 |
| 14 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.43598100 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.36493523 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.30267740 |
| 17 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.22593888 |
| 18 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.20235806 |
| 19 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.20206303 |
| 20 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.20138503 |
| 21 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.17417459 |
| 22 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.15861265 |
| 23 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.14556524 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.10904457 |
| 25 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.09142450 |
| 26 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.07837179 |
| 27 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.06817813 |
| 28 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.04537565 |
| 29 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.02513068 |
| 30 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02371518 |
| 31 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.97409986 |
| 32 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.93027410 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.92443350 |
| 34 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.90379644 |
| 35 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.87191792 |
| 36 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.86849380 |
| 37 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.85012473 |
| 38 | EWS_26573619_Chip-Seq_HEK293_Human | 1.82339724 |
| 39 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.78026659 |
| 40 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.76827170 |
| 41 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.76498891 |
| 42 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.75210774 |
| 43 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.74930512 |
| 44 | * MYB_26560356_Chip-Seq_TH2_Human | 1.74240987 |
| 45 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.71877696 |
| 46 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70678735 |
| 47 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.68690666 |
| 48 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.67057848 |
| 49 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.63316805 |
| 50 | MYC_22102868_ChIP-Seq_BL_Human | 1.63283033 |
| 51 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.62082530 |
| 52 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.57043657 |
| 53 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.55704651 |
| 54 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.54231220 |
| 55 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.53905225 |
| 56 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.53705463 |
| 57 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51819574 |
| 58 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.51748211 |
| 59 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.50973869 |
| 60 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.50242296 |
| 61 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.48566666 |
| 62 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.48158831 |
| 63 | FUS_26573619_Chip-Seq_HEK293_Human | 1.47267197 |
| 64 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.46869853 |
| 65 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.46833757 |
| 66 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.46652604 |
| 67 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.45887681 |
| 68 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.45130715 |
| 69 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.44721474 |
| 70 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.42965342 |
| 71 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.41898762 |
| 72 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.40210172 |
| 73 | * MYB_26560356_Chip-Seq_TH1_Human | 1.39781319 |
| 74 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.39282990 |
| 75 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.37775958 |
| 76 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.37734110 |
| 77 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.32613864 |
| 78 | * MAF_26560356_Chip-Seq_TH1_Human | 1.32061726 |
| 79 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.32031957 |
| 80 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.30572118 |
| 81 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.28084528 |
| 82 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.27927676 |
| 83 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.27222607 |
| 84 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24882454 |
| 85 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.24401761 |
| 86 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.24296880 |
| 87 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.23968244 |
| 88 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.22662837 |
| 89 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.19823019 |
| 90 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.19411239 |
| 91 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.16990168 |
| 92 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16867529 |
| 93 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.16216082 |
| 94 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.16047061 |
| 95 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.15237795 |
| 96 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.14423364 |
| 97 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13872751 |
| 98 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.13650523 |
| 99 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.13645720 |
| 100 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.13310720 |
| 101 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.12867330 |
| 102 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12541745 |
| 103 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11563199 |
| 104 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11513538 |
| 105 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.11463571 |
| 106 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.10921253 |
| 107 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.10186000 |
| 108 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.09909031 |
| 109 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.09310772 |
| 110 | VDR_22108803_ChIP-Seq_LS180_Human | 1.07842327 |
| 111 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.06723634 |
| 112 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.05112976 |
| 113 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.04097889 |
| 114 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.03938947 |
| 115 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.03442919 |
| 116 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.02708949 |
| 117 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.02242635 |
| 118 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.00811827 |
| 119 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.99211837 |
| 120 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.98808175 |
| 121 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.98486550 |
| 122 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.98341630 |
| 123 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.97480311 |
| 124 | * TTF2_22483619_ChIP-Seq_HELA_Human | 0.97469794 |
| 125 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.96117371 |
| 126 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.95760974 |
| 127 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.94728387 |
| 128 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.93089712 |
| 129 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.92961228 |
| 130 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.89121524 |
| 131 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.88394951 |
| 132 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.85073257 |
| 133 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.84892884 |
| 134 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.83507998 |
| 135 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.81239340 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006054_spinal_hemorrhage | 3.72386747 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.03776822 |
| 3 | MP0005671_abnormal_response_to | 2.44135140 |
| 4 | MP0002166_altered_tumor_susceptibility | 2.42147014 |
| 5 | MP0002396_abnormal_hematopoietic_system | 2.41013451 |
| 6 | MP0000685_abnormal_immune_system | 2.35753036 |
| 7 | MP0003763_abnormal_thymus_physiology | 2.22836782 |
| 8 | MP0008932_abnormal_embryonic_tissue | 2.16221289 |
| 9 | MP0009785_altered_susceptibility_to | 2.14608881 |
| 10 | MP0008007_abnormal_cellular_replicative | 2.02350079 |
| 11 | MP0008877_abnormal_DNA_methylation | 1.99351810 |
| 12 | MP0001800_abnormal_humoral_immune | 1.98608181 |
| 13 | MP0002009_preneoplasia | 1.92325428 |
| 14 | MP0006072_abnormal_retinal_apoptosis | 1.91403501 |
| 15 | MP0001879_abnormal_lymphatic_vessel | 1.83892692 |
| 16 | MP0008995_early_reproductive_senescence | 1.83784699 |
| 17 | MP0003786_premature_aging | 1.83571248 |
| 18 | MP0002452_abnormal_antigen_presenting | 1.81312238 |
| 19 | MP0004147_increased_porphyrin_level | 1.75052313 |
| 20 | MP0002398_abnormal_bone_marrow | 1.74976970 |
| 21 | MP0002420_abnormal_adaptive_immunity | 1.72751451 |
| 22 | MP0005000_abnormal_immune_tolerance | 1.72739066 |
| 23 | MP0004808_abnormal_hematopoietic_stem | 1.72346245 |
| 24 | MP0002006_tumorigenesis | 1.71691243 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 1.70335169 |
| 26 | MP0003724_increased_susceptibility_to | 1.68960781 |
| 27 | MP0001819_abnormal_immune_cell | 1.68921349 |
| 28 | MP0005025_abnormal_response_to | 1.67388555 |
| 29 | MP0001853_heart_inflammation | 1.64100190 |
| 30 | MP0002723_abnormal_immune_serum | 1.60974127 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.57381173 |
| 32 | MP0005387_immune_system_phenotype | 1.56410442 |
| 33 | MP0001790_abnormal_immune_system | 1.56410442 |
| 34 | MP0003221_abnormal_cardiomyocyte_apopto | 1.55707316 |
| 35 | MP0003806_abnormal_nucleotide_metabolis | 1.54701638 |
| 36 | MP0003436_decreased_susceptibility_to | 1.54318080 |
| 37 | MP0006292_abnormal_olfactory_placode | 1.53366869 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.52951335 |
| 39 | MP0000490_abnormal_crypts_of | 1.52784960 |
| 40 | MP0002419_abnormal_innate_immunity | 1.52726381 |
| 41 | MP0000716_abnormal_immune_system | 1.51735383 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.51038504 |
| 43 | MP0010307_abnormal_tumor_latency | 1.50421159 |
| 44 | MP0003718_maternal_effect | 1.48465799 |
| 45 | MP0003077_abnormal_cell_cycle | 1.47991356 |
| 46 | MP0003943_abnormal_hepatobiliary_system | 1.47070662 |
| 47 | MP0005464_abnormal_platelet_physiology | 1.46324181 |
| 48 | MP0003890_abnormal_embryonic-extraembry | 1.46317660 |
| 49 | MP0002722_abnormal_immune_system | 1.45342634 |
| 50 | MP0003693_abnormal_embryo_hatching | 1.41830524 |
| 51 | MP0002429_abnormal_blood_cell | 1.41647951 |
| 52 | MP0000465_gastrointestinal_hemorrhage | 1.41117512 |
| 53 | MP0001730_embryonic_growth_arrest | 1.40930293 |
| 54 | MP0002132_abnormal_respiratory_system | 1.40382505 |
| 55 | MP0001727_abnormal_embryo_implantation | 1.40295585 |
| 56 | MP0010368_abnormal_lymphatic_system | 1.39672414 |
| 57 | MP0008438_abnormal_cutaneous_collagen | 1.38874448 |
| 58 | MP0001293_anophthalmia | 1.35545307 |
| 59 | MP0010094_abnormal_chromosome_stability | 1.35312721 |
| 60 | MP0002405_respiratory_system_inflammati | 1.33835971 |
| 61 | MP0006035_abnormal_mitochondrial_morpho | 1.33704766 |
| 62 | MP0006036_abnormal_mitochondrial_physio | 1.32244740 |
| 63 | MP0003186_abnormal_redox_activity | 1.31071668 |
| 64 | MP0001764_abnormal_homeostasis | 1.26153606 |
| 65 | MP0008057_abnormal_DNA_replication | 1.25712458 |
| 66 | MP0005397_hematopoietic_system_phenotyp | 1.21420933 |
| 67 | MP0001545_abnormal_hematopoietic_system | 1.21420933 |
| 68 | MP0001672_abnormal_embryogenesis/_devel | 1.21349943 |
| 69 | MP0005380_embryogenesis_phenotype | 1.21349943 |
| 70 | MP0008058_abnormal_DNA_repair | 1.21269847 |
| 71 | MP0001873_stomach_inflammation | 1.21095710 |
| 72 | MP0001845_abnormal_inflammatory_respons | 1.20917819 |
| 73 | MP0000703_abnormal_thymus_morphology | 1.20482032 |
| 74 | MP0009697_abnormal_copulation | 1.20212209 |
| 75 | MP0005253_abnormal_eye_physiology | 1.12746143 |
| 76 | MP0004957_abnormal_blastocyst_morpholog | 1.10911972 |
| 77 | MP0009384_cardiac_valve_regurgitation | 1.09666636 |
| 78 | MP0000858_altered_metastatic_potential | 1.09362119 |
| 79 | MP0003300_gastrointestinal_ulcer | 1.09203978 |
| 80 | MP0001697_abnormal_embryo_size | 1.08823581 |
| 81 | MP0001529_abnormal_vocalization | 1.08175361 |
| 82 | MP0003279_aneurysm | 1.07074562 |
| 83 | MP0008789_abnormal_olfactory_epithelium | 1.06203592 |
| 84 | MP0003984_embryonic_growth_retardation | 1.06161587 |
| 85 | MP0000372_irregular_coat_pigmentation | 1.04112827 |
| 86 | MP0002088_abnormal_embryonic_growth/wei | 1.03855358 |
| 87 | MP0000343_altered_response_to | 1.01663609 |
| 88 | MP0005503_abnormal_tendon_morphology | 1.01481843 |
| 89 | MP0005367_renal/urinary_system_phenotyp | 1.01225504 |
| 90 | MP0000516_abnormal_urinary_system | 1.01225504 |
| 91 | MP0003787_abnormal_imprinting | 0.99905405 |
| 92 | MP0002102_abnormal_ear_morphology | 0.99675221 |
| 93 | MP0003941_abnormal_skin_development | 0.99402291 |
| 94 | MP0008469_abnormal_protein_level | 0.97806957 |
| 95 | MP0001915_intracranial_hemorrhage | 0.96391671 |
| 96 | MP0002933_joint_inflammation | 0.94995732 |
| 97 | MP0002080_prenatal_lethality | 0.94782528 |
| 98 | MP0002019_abnormal_tumor_incidence | 0.94077685 |
| 99 | MP0003567_abnormal_fetal_cardiomyocyte | 0.91936019 |
| 100 | MP0005248_abnormal_Harderian_gland | 0.90097134 |
| 101 | MP0005275_abnormal_skin_tensile | 0.88653896 |
| 102 | MP0001533_abnormal_skeleton_physiology | 0.88257839 |
| 103 | MP0003656_abnormal_erythrocyte_physiolo | 0.87704159 |
| 104 | MP0000358_abnormal_cell_content/ | 0.86814059 |
| 105 | MP0006082_CNS_inflammation | 0.86801351 |
| 106 | MP0005220_abnormal_exocrine_pancreas | 0.86355620 |
| 107 | MP0003866_abnormal_defecation | 0.86163807 |
| 108 | MP0001929_abnormal_gametogenesis | 0.85254787 |
| 109 | MP0002090_abnormal_vision | 0.84991961 |
| 110 | MP0004947_skin_inflammation | 0.84442791 |
| 111 | MP0002095_abnormal_skin_pigmentation | 0.84075463 |
| 112 | MP0003111_abnormal_nucleus_morphology | 0.83859666 |
| 113 | MP0004264_abnormal_extraembryonic_tissu | 0.83399349 |
| 114 | MP0005023_abnormal_wound_healing | 0.82706918 |
| 115 | MP0002138_abnormal_hepatobiliary_system | 0.81063304 |
| 116 | MP0002086_abnormal_extraembryonic_tissu | 0.79448663 |
| 117 | MP0004197_abnormal_fetal_growth/weight/ | 0.79315580 |
| 118 | MP0002938_white_spotting | 0.78473363 |
| 119 | MP0010352_gastrointestinal_tract_polyps | 0.77113875 |
| 120 | MP0003828_pulmonary_edema | 0.76563855 |
| 121 | MP0001119_abnormal_female_reproductive | 0.75701038 |
| 122 | MP0003195_calcinosis | 0.75553587 |
| 123 | MP0002928_abnormal_bile_duct | 0.75421315 |
| 124 | MP0005058_abnormal_lysosome_morphology | 0.74876849 |
| 125 | MP0002751_abnormal_autonomic_nervous | 0.74407557 |
| 126 | MP0005075_abnormal_melanosome_morpholog | 0.74349160 |
| 127 | MP0002084_abnormal_developmental_patter | 0.72940649 |
| 128 | MP0001243_abnormal_dermal_layer | 0.70591734 |
| 129 | MP0000313_abnormal_cell_death | 0.69853204 |
| 130 | MP0000767_abnormal_smooth_muscle | 0.69581264 |
| 131 | MP0005174_abnormal_tail_pigmentation | 0.69400795 |
| 132 | MP0003191_abnormal_cellular_cholesterol | 0.69151016 |
| 133 | MP0000598_abnormal_liver_morphology | 0.68649454 |
| 134 | MP0000350_abnormal_cell_proliferation | 0.68336993 |
| 135 | MP0000249_abnormal_blood_vessel | 0.68007534 |
| 136 | MP0009278_abnormal_bone_marrow | 0.67798624 |
| 137 | MP0004782_abnormal_surfactant_physiolog | 0.67166075 |
| 138 | MP0009643_abnormal_urine_homeostasis | 0.67100605 |
| 139 | MP0009764_decreased_sensitivity_to | 0.67085572 |
| 140 | MP0005084_abnormal_gallbladder_morpholo | 0.66976102 |
| 141 | MP0000477_abnormal_intestine_morphology | 0.66736084 |
| 142 | MP0009763_increased_sensitivity_to | 0.66175923 |
| 143 | MP0002060_abnormal_skin_morphology | 0.65594977 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Thrombocytosis (HP:0001894) | 3.63087082 |
| 2 | IgM deficiency (HP:0002850) | 3.50282071 |
| 3 | Chronic otitis media (HP:0000389) | 3.46382435 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.18403561 |
| 5 | Gastrointestinal stroma tumor (HP:0100723) | 3.15375742 |
| 6 | Aplastic anemia (HP:0001915) | 3.06273354 |
| 7 | Recurrent abscess formation (HP:0002722) | 3.05798887 |
| 8 | Recurrent bronchitis (HP:0002837) | 2.98766407 |
| 9 | Agammaglobulinemia (HP:0004432) | 2.96355353 |
| 10 | Medulloblastoma (HP:0002885) | 2.87310627 |
| 11 | Myositis (HP:0100614) | 2.86061604 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 2.78658352 |
| 13 | Stomach cancer (HP:0012126) | 2.77830196 |
| 14 | Recurrent viral infections (HP:0004429) | 2.70253096 |
| 15 | Lipid accumulation in hepatocytes (HP:0006561) | 2.70080159 |
| 16 | Volvulus (HP:0002580) | 2.70002302 |
| 17 | T lymphocytopenia (HP:0005403) | 2.68785165 |
| 18 | Abnormality of T cell number (HP:0011839) | 2.64965931 |
| 19 | Increased hepatocellular lipid droplets (HP:0006565) | 2.63070465 |
| 20 | Petechiae (HP:0000967) | 2.61466406 |
| 21 | Hematochezia (HP:0002573) | 2.60312960 |
| 22 | Lymphopenia (HP:0001888) | 2.58976032 |
| 23 | Cellulitis (HP:0100658) | 2.58514497 |
| 24 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.56938737 |
| 25 | Abnormal number of erythroid precursors (HP:0012131) | 2.55971175 |
| 26 | Abnormality of T cells (HP:0002843) | 2.53267775 |
| 27 | Reticulocytopenia (HP:0001896) | 2.52722470 |
| 28 | Rhabdomyosarcoma (HP:0002859) | 2.52069511 |
| 29 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.50134412 |
| 30 | Thyroid carcinoma (HP:0002890) | 2.48579347 |
| 31 | Neoplasm of the colon (HP:0100273) | 2.47394291 |
| 32 | Gonadotropin excess (HP:0000837) | 2.44062193 |
| 33 | Abnormality of chromosome stability (HP:0003220) | 2.43910757 |
| 34 | Abnormal lung lobation (HP:0002101) | 2.43698452 |
| 35 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.41980660 |
| 36 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.41757589 |
| 37 | Abnormality of the labia minora (HP:0012880) | 2.41735304 |
| 38 | Microvesicular hepatic steatosis (HP:0001414) | 2.41055259 |
| 39 | Type I transferrin isoform profile (HP:0003642) | 2.40578594 |
| 40 | Neoplasm of the adrenal gland (HP:0100631) | 2.40466365 |
| 41 | Ovarian neoplasm (HP:0100615) | 2.39381976 |
| 42 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.38715876 |
| 43 | Dyschromatopsia (HP:0007641) | 2.38556682 |
| 44 | Abnormality of methionine metabolism (HP:0010901) | 2.38205922 |
| 45 | Abnormality of T cell physiology (HP:0011840) | 2.38086934 |
| 46 | 11 pairs of ribs (HP:0000878) | 2.34566378 |
| 47 | Vacuolated lymphocytes (HP:0001922) | 2.34386612 |
| 48 | IgG deficiency (HP:0004315) | 2.33507470 |
| 49 | Embryonal renal neoplasm (HP:0011794) | 2.33241764 |
| 50 | Methylmalonic acidemia (HP:0002912) | 2.29809886 |
| 51 | Hyperglycinuria (HP:0003108) | 2.28617227 |
| 52 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.28460702 |
| 53 | Glioma (HP:0009733) | 2.27643052 |
| 54 | Cortical dysplasia (HP:0002539) | 2.27311475 |
| 55 | Spondylolisthesis (HP:0003302) | 2.25713612 |
| 56 | Hyperglycinemia (HP:0002154) | 2.25622319 |
| 57 | Degeneration of anterior horn cells (HP:0002398) | 2.24429650 |
| 58 | Abnormality of the anterior horn cell (HP:0006802) | 2.24429650 |
| 59 | Reduced antithrombin III activity (HP:0001976) | 2.24206142 |
| 60 | Lymphoma (HP:0002665) | 2.22069278 |
| 61 | Nonimmune hydrops fetalis (HP:0001790) | 2.22048851 |
| 62 | Myelodysplasia (HP:0002863) | 2.19919389 |
| 63 | Biconcave vertebral bodies (HP:0004586) | 2.19736402 |
| 64 | Carpal bone hypoplasia (HP:0001498) | 2.18881372 |
| 65 | Breast carcinoma (HP:0003002) | 2.16183837 |
| 66 | Ependymoma (HP:0002888) | 2.16167279 |
| 67 | Colon cancer (HP:0003003) | 2.15482685 |
| 68 | Central scotoma (HP:0000603) | 2.12705616 |
| 69 | Meningitis (HP:0001287) | 2.12460932 |
| 70 | Chromsome breakage (HP:0040012) | 2.09528323 |
| 71 | IgA deficiency (HP:0002720) | 2.09394306 |
| 72 | Spontaneous hematomas (HP:0007420) | 2.09273908 |
| 73 | Neoplasm of the small intestine (HP:0100833) | 2.08915891 |
| 74 | Papillary thyroid carcinoma (HP:0002895) | 2.06300645 |
| 75 | Chronic diarrhea (HP:0002028) | 2.05626403 |
| 76 | Acute myeloid leukemia (HP:0004808) | 2.05202416 |
| 77 | Osteomyelitis (HP:0002754) | 2.05044577 |
| 78 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.04577203 |
| 79 | Abnormality of male internal genitalia (HP:0000022) | 2.04027670 |
| 80 | Biliary tract neoplasm (HP:0100574) | 2.02870761 |
| 81 | Abnormality of serum amino acid levels (HP:0003112) | 2.01683097 |
| 82 | Panhypogammaglobulinemia (HP:0003139) | 2.01571568 |
| 83 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.00821717 |
| 84 | Abnormality of glycine metabolism (HP:0010895) | 2.00821717 |
| 85 | Generalized aminoaciduria (HP:0002909) | 1.99993105 |
| 86 | Progressive external ophthalmoplegia (HP:0000590) | 1.97615607 |
| 87 | Recurrent skin infections (HP:0001581) | 1.96247350 |
| 88 | Aortic aneurysm (HP:0004942) | 1.96106158 |
| 89 | Autoimmune hemolytic anemia (HP:0001890) | 1.95980313 |
| 90 | Broad face (HP:0000283) | 1.94883508 |
| 91 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.93522789 |
| 92 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.93522789 |
| 93 | Abnormal protein glycosylation (HP:0012346) | 1.93522789 |
| 94 | Abnormal glycosylation (HP:0012345) | 1.93522789 |
| 95 | Abnormality of the prostate (HP:0008775) | 1.93398582 |
| 96 | Eczematoid dermatitis (HP:0000976) | 1.92072407 |
| 97 | Cutaneous melanoma (HP:0012056) | 1.91600887 |
| 98 | Prolonged bleeding time (HP:0003010) | 1.90983487 |
| 99 | Sloping forehead (HP:0000340) | 1.90835829 |
| 100 | Abnormality of vitamin B metabolism (HP:0004340) | 1.90398253 |
| 101 | 3-Methylglutaconic aciduria (HP:0003535) | 1.90084023 |
| 102 | Short middle phalanx of the 5th finger (HP:0004220) | 1.89674973 |
| 103 | Intestinal atresia (HP:0011100) | 1.88786845 |
| 104 | Cystic hygroma (HP:0000476) | 1.87546610 |
| 105 | Basal cell carcinoma (HP:0002671) | 1.87532128 |
| 106 | Median cleft lip (HP:0000161) | 1.86543060 |
| 107 | Hypoplasia of the thymus (HP:0000778) | 1.86180602 |
| 108 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.86104035 |
| 109 | Thyroiditis (HP:0100646) | 1.85931398 |
| 110 | Recurrent fungal infections (HP:0002841) | 1.85815815 |
| 111 | Agnosia (HP:0010524) | 1.85333013 |
| 112 | Meckel diverticulum (HP:0002245) | 1.83318636 |
| 113 | Abnormality of B cell number (HP:0010975) | 1.82812524 |
| 114 | B lymphocytopenia (HP:0010976) | 1.82812524 |
| 115 | Onycholysis (HP:0001806) | 1.82691971 |
| 116 | Limb hypertonia (HP:0002509) | 1.82682404 |
| 117 | Neutropenia (HP:0001875) | 1.80952648 |
| 118 | Gastrointestinal inflammation (HP:0004386) | 1.80406667 |
| 119 | Posterior subcapsular cataract (HP:0007787) | 1.80308861 |
| 120 | Aortic valve stenosis (HP:0001650) | 1.80166774 |
| 121 | Abnormality of macular pigmentation (HP:0008002) | 1.79849960 |
| 122 | Syringomyelia (HP:0003396) | 1.79834606 |
| 123 | Spinal cord lesions (HP:0100561) | 1.79834606 |
| 124 | Mediastinal lymphadenopathy (HP:0100721) | 1.79500421 |
| 125 | Palpitations (HP:0001962) | 1.78832655 |
| 126 | Vasculitis (HP:0002633) | 1.78814934 |
| 127 | Encephalitis (HP:0002383) | 1.78772708 |
| 128 | Colitis (HP:0002583) | 1.78707879 |
| 129 | Methylmalonic aciduria (HP:0012120) | 1.78564263 |
| 130 | Curly hair (HP:0002212) | 1.78246539 |
| 131 | Epistaxis (HP:0000421) | 1.77895299 |
| 132 | Inflammation of the large intestine (HP:0002037) | 1.77886871 |
| 133 | Emphysema (HP:0002097) | 1.77755176 |
| 134 | Papilloma (HP:0012740) | 1.77487340 |
| 135 | Verrucae (HP:0200043) | 1.77487340 |
| 136 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.77013684 |
| 137 | Short 4th metacarpal (HP:0010044) | 1.76631291 |
| 138 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.76631291 |
| 139 | Increased serum lactate (HP:0002151) | 1.75668372 |
| 140 | Periodontitis (HP:0000704) | 1.75385361 |
| 141 | Autoimmune thrombocytopenia (HP:0001973) | 1.74901163 |
| 142 | Microretrognathia (HP:0000308) | 1.74849073 |
| 143 | Prostate neoplasm (HP:0100787) | 1.73935718 |
| 144 | Severe combined immunodeficiency (HP:0004430) | 1.73531978 |
| 145 | Duodenal stenosis (HP:0100867) | 1.72964446 |
| 146 | Small intestinal stenosis (HP:0012848) | 1.72964446 |
| 147 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.72821077 |
| 148 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.72821077 |
| 149 | Abnormality of homocysteine metabolism (HP:0010919) | 1.72804699 |
| 150 | Homocystinuria (HP:0002156) | 1.72804699 |
| 151 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.72788586 |
| 152 | Neuroendocrine neoplasm (HP:0100634) | 1.71819609 |
| 153 | Orchitis (HP:0100796) | 1.71770831 |
| 154 | Recurrent sinusitis (HP:0011108) | 1.70826240 |
| 155 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.70611739 |
| 156 | Abnormal spermatogenesis (HP:0008669) | 1.70535357 |
| 157 | Combined immunodeficiency (HP:0005387) | 1.70403434 |
| 158 | Increased serum pyruvate (HP:0003542) | 1.69941999 |
| 159 | Bile duct proliferation (HP:0001408) | 1.69908653 |
| 160 | Abnormal biliary tract physiology (HP:0012439) | 1.69908653 |
| 161 | Abnormality of the ileum (HP:0001549) | 1.69901855 |
| 162 | Abnormality of eosinophils (HP:0001879) | 1.67803365 |
| 163 | Meningioma (HP:0002858) | 1.67543586 |
| 164 | Acanthocytosis (HP:0001927) | 1.67457197 |
| 165 | Impaired platelet aggregation (HP:0003540) | 1.66623702 |
| 166 | Abnormal platelet function (HP:0011869) | 1.66623702 |
| 167 | Bicuspid aortic valve (HP:0001647) | 1.66515809 |
| 168 | Skin ulcer (HP:0200042) | 1.66454405 |
| 169 | Granulocytopenia (HP:0001913) | 1.65028776 |
| 170 | Recurrent pneumonia (HP:0006532) | 1.64811929 |
| 171 | Amaurosis fugax (HP:0100576) | 1.64204816 |
| 172 | Abnormality of macrophages (HP:0004311) | 1.63991602 |
| 173 | Mucosal telangiectasiae (HP:0100579) | 1.62746387 |
| 174 | Aortic dissection (HP:0002647) | 1.62456137 |
| 175 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.62245123 |
| 176 | Skin rash (HP:0000988) | 1.61999151 |
| 177 | Keratoconjunctivitis sicca (HP:0001097) | 1.60841267 |
| 178 | Interstitial pulmonary disease (HP:0006530) | 1.60213011 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 2.90850957 |
| 2 | TGFBR1 | 2.90376746 |
| 3 | NEK1 | 2.89886598 |
| 4 | TTK | 2.69781091 |
| 5 | MAP4K2 | 2.47465749 |
| 6 | TSSK6 | 2.37799885 |
| 7 | MAP4K1 | 2.37627191 |
| 8 | FLT3 | 2.29198294 |
| 9 | TGFBR2 | 2.23013022 |
| 10 | TEC | 2.19226320 |
| 11 | KIT | 2.14487763 |
| 12 | TRIM28 | 2.08017181 |
| 13 | PLK3 | 2.01278290 |
| 14 | BCR | 2.00851363 |
| 15 | STK10 | 1.96568853 |
| 16 | IRAK4 | 1.91400308 |
| 17 | RPS6KA4 | 1.83511952 |
| 18 | TYK2 | 1.82548846 |
| 19 | FRK | 1.82210232 |
| 20 | MST4 | 1.81025056 |
| 21 | PASK | 1.80125201 |
| 22 | NEK9 | 1.79190239 |
| 23 | CDK19 | 1.76260001 |
| 24 | ITK | 1.75886308 |
| 25 | BUB1 | 1.74830111 |
| 26 | BTK | 1.74140891 |
| 27 | MAP3K14 | 1.69517404 |
| 28 | TXK | 1.68794952 |
| 29 | JAK3 | 1.62383764 |
| 30 | CSF1R | 1.52375703 |
| 31 | LRRK2 | 1.50124333 |
| 32 | MKNK1 | 1.49868707 |
| 33 | BRSK2 | 1.48247432 |
| 34 | TBK1 | 1.45423251 |
| 35 | DYRK3 | 1.44357753 |
| 36 | STK16 | 1.41067744 |
| 37 | BMPR1B | 1.40757888 |
| 38 | TAF1 | 1.40101937 |
| 39 | NUAK1 | 1.37845688 |
| 40 | NME2 | 1.37493826 |
| 41 | TIE1 | 1.36975247 |
| 42 | BRD4 | 1.36369719 |
| 43 | SIK3 | 1.35361700 |
| 44 | SRPK1 | 1.31383096 |
| 45 | KDR | 1.30637723 |
| 46 | IKBKE | 1.26961904 |
| 47 | ERN1 | 1.25670274 |
| 48 | PIK3CG | 1.24563892 |
| 49 | CLK1 | 1.24440936 |
| 50 | EIF2AK1 | 1.23077972 |
| 51 | VRK2 | 1.22435121 |
| 52 | STK4 | 1.18194677 |
| 53 | STK3 | 1.18158217 |
| 54 | NLK | 1.17955862 |
| 55 | BCKDK | 1.14674171 |
| 56 | ZAP70 | 1.10113099 |
| 57 | VRK1 | 1.08830378 |
| 58 | IKBKB | 1.08787560 |
| 59 | MELK | 1.06225070 |
| 60 | PLK1 | 1.06016215 |
| 61 | BMPR2 | 1.05869628 |
| 62 | TAOK3 | 1.04416474 |
| 63 | CDK8 | 1.01963356 |
| 64 | PIM2 | 1.01541170 |
| 65 | WNK3 | 1.00210882 |
| 66 | FGFR3 | 0.97160769 |
| 67 | PIM1 | 0.97038278 |
| 68 | WEE1 | 0.94931175 |
| 69 | CHUK | 0.94347062 |
| 70 | MAP2K3 | 0.92629919 |
| 71 | ERBB3 | 0.92316047 |
| 72 | JAK1 | 0.88524229 |
| 73 | PLK2 | 0.85504001 |
| 74 | EIF2AK3 | 0.85191282 |
| 75 | AURKB | 0.85185343 |
| 76 | LYN | 0.83520728 |
| 77 | ZAK | 0.80361413 |
| 78 | LCK | 0.77301129 |
| 79 | MYLK | 0.77172635 |
| 80 | EIF2AK2 | 0.76155627 |
| 81 | SCYL2 | 0.75277261 |
| 82 | NEK2 | 0.72465620 |
| 83 | PAK4 | 0.72054264 |
| 84 | CDK6 | 0.70986224 |
| 85 | CDK9 | 0.70861994 |
| 86 | MAP3K4 | 0.70252795 |
| 87 | IRAK3 | 0.70132321 |
| 88 | YES1 | 0.69777666 |
| 89 | CSNK1G3 | 0.69495666 |
| 90 | SYK | 0.68757945 |
| 91 | MAP3K10 | 0.68032299 |
| 92 | PBK | 0.67732372 |
| 93 | CDC7 | 0.67637593 |
| 94 | ATR | 0.66974525 |
| 95 | RPS6KB2 | 0.66777290 |
| 96 | FGFR4 | 0.65718525 |
| 97 | CSNK1G2 | 0.64024360 |
| 98 | PTK6 | 0.63941164 |
| 99 | CHEK2 | 0.63875570 |
| 100 | MAPK11 | 0.62999601 |
| 101 | CSNK1G1 | 0.62554558 |
| 102 | MATK | 0.61586365 |
| 103 | PKN2 | 0.61027209 |
| 104 | ATM | 0.59852537 |
| 105 | PLK4 | 0.59208156 |
| 106 | BLK | 0.56874379 |
| 107 | CSNK1A1L | 0.55971713 |
| 108 | EPHA3 | 0.55931675 |
| 109 | MKNK2 | 0.54540144 |
| 110 | PIK3CA | 0.52960498 |
| 111 | ALK | 0.52366188 |
| 112 | TRPM7 | 0.50665351 |
| 113 | CSK | 0.49120134 |
| 114 | RAF1 | 0.49120098 |
| 115 | GRK6 | 0.48879889 |
| 116 | BRSK1 | 0.48603323 |
| 117 | DYRK1B | 0.48278626 |
| 118 | STK38L | 0.47997319 |
| 119 | CDK4 | 0.47848478 |
| 120 | CCNB1 | 0.47077119 |
| 121 | CHEK1 | 0.46583292 |
| 122 | TRIB3 | 0.46303461 |
| 123 | MAPKAPK2 | 0.46208970 |
| 124 | MAP3K8 | 0.44863152 |
| 125 | IGF1R | 0.44689336 |
| 126 | RPS6KA6 | 0.43996061 |
| 127 | TNIK | 0.43106801 |
| 128 | EEF2K | 0.42590479 |
| 129 | HIPK2 | 0.42044934 |
| 130 | IRAK1 | 0.41833408 |
| 131 | CDK3 | 0.37672840 |
| 132 | CSNK2A1 | 0.37494082 |
| 133 | OXSR1 | 0.35009911 |
| 134 | STK24 | 0.32938582 |
| 135 | MAP3K5 | 0.32606575 |
| 136 | RPS6KA5 | 0.30007665 |
| 137 | MARK3 | 0.29279321 |
| 138 | EGFR | 0.29185267 |
| 139 | CSNK2A2 | 0.29068280 |
| 140 | PRKCQ | 0.28989840 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.14732974 |
| 2 | Base excision repair_Homo sapiens_hsa03410 | 2.78098835 |
| 3 | Protein export_Homo sapiens_hsa03060 | 2.61884944 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.56664933 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 2.49906419 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.40419311 |
| 7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.20837203 |
| 8 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.02278579 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.91783428 |
| 10 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.89886027 |
| 11 | Homologous recombination_Homo sapiens_hsa03440 | 1.79846324 |
| 12 | Spliceosome_Homo sapiens_hsa03040 | 1.69533957 |
| 13 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.68899384 |
| 14 | Asthma_Homo sapiens_hsa05310 | 1.67091026 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.66293490 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.61635509 |
| 17 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.58994202 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.58462661 |
| 19 | Cell cycle_Homo sapiens_hsa04110 | 1.57584161 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.53557083 |
| 21 | Legionellosis_Homo sapiens_hsa05134 | 1.52533944 |
| 22 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.48547526 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.42745690 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.42146385 |
| 25 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.39029127 |
| 26 | Leishmaniasis_Homo sapiens_hsa05140 | 1.38398875 |
| 27 | Proteasome_Homo sapiens_hsa03050 | 1.37805480 |
| 28 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.36349111 |
| 29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.35477557 |
| 30 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.32892960 |
| 31 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.31166219 |
| 32 | RNA degradation_Homo sapiens_hsa03018 | 1.26342159 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.25948358 |
| 34 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.20838246 |
| 35 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.17863748 |
| 36 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.12338039 |
| 37 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.12106519 |
| 38 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.10963773 |
| 39 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.10572563 |
| 40 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.09819355 |
| 41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.07602894 |
| 42 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.07292301 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.06033305 |
| 44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.03991669 |
| 45 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.03294135 |
| 46 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.03216403 |
| 47 | Malaria_Homo sapiens_hsa05144 | 1.00827891 |
| 48 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.00520083 |
| 49 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.98830207 |
| 50 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.98367186 |
| 51 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.97973633 |
| 52 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.96596870 |
| 53 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.95095659 |
| 54 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.92269727 |
| 55 | Apoptosis_Homo sapiens_hsa04210 | 0.90853886 |
| 56 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.90139889 |
| 57 | Purine metabolism_Homo sapiens_hsa00230 | 0.90046816 |
| 58 | RNA polymerase_Homo sapiens_hsa03020 | 0.89595845 |
| 59 | Allograft rejection_Homo sapiens_hsa05330 | 0.88384140 |
| 60 | Influenza A_Homo sapiens_hsa05164 | 0.87525160 |
| 61 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.87176439 |
| 62 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.86833347 |
| 63 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.86489694 |
| 64 | Hepatitis B_Homo sapiens_hsa05161 | 0.86025090 |
| 65 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.85700087 |
| 66 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.85349511 |
| 67 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.82846686 |
| 68 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.82551235 |
| 69 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82257519 |
| 70 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.81193066 |
| 71 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.80623608 |
| 72 | Other glycan degradation_Homo sapiens_hsa00511 | 0.79852675 |
| 73 | RNA transport_Homo sapiens_hsa03013 | 0.79842224 |
| 74 | Basal transcription factors_Homo sapiens_hsa03022 | 0.79592477 |
| 75 | HTLV-I infection_Homo sapiens_hsa05166 | 0.78297467 |
| 76 | Peroxisome_Homo sapiens_hsa04146 | 0.77473818 |
| 77 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.76882568 |
| 78 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.76354679 |
| 79 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.75688129 |
| 80 | Viral myocarditis_Homo sapiens_hsa05416 | 0.75672314 |
| 81 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.73706822 |
| 82 | Thyroid cancer_Homo sapiens_hsa05216 | 0.72166272 |
| 83 | Shigellosis_Homo sapiens_hsa05131 | 0.72127102 |
| 84 | Carbon metabolism_Homo sapiens_hsa01200 | 0.72031193 |
| 85 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.71592136 |
| 86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.71173480 |
| 87 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.70952754 |
| 88 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.70678889 |
| 89 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.70322610 |
| 90 | Hepatitis C_Homo sapiens_hsa05160 | 0.68400427 |
| 91 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.67992669 |
| 92 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.67752215 |
| 93 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.67119730 |
| 94 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.66040256 |
| 95 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.65436355 |
| 96 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.65029234 |
| 97 | Platelet activation_Homo sapiens_hsa04611 | 0.65010732 |
| 98 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.64593604 |
| 99 | Pertussis_Homo sapiens_hsa05133 | 0.63985739 |
| 100 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.63669521 |
| 101 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.63531459 |
| 102 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.62564678 |
| 103 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.61147409 |
| 104 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.60931180 |
| 105 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58984630 |
| 106 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.57342188 |
| 107 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.56354532 |
| 108 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.55769432 |
| 109 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.54962090 |
| 110 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.53514570 |
| 111 | Sulfur relay system_Homo sapiens_hsa04122 | 0.51743926 |
| 112 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.50538914 |
| 113 | Parkinsons disease_Homo sapiens_hsa05012 | 0.50361796 |
| 114 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49669797 |
| 115 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.49408242 |
| 116 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.48745046 |
| 117 | Colorectal cancer_Homo sapiens_hsa05210 | 0.48440896 |
| 118 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.48316292 |
| 119 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.47787995 |
| 120 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.47495485 |
| 121 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.46264184 |
| 122 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.46069581 |
| 123 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.46046437 |
| 124 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.45604946 |
| 125 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.45310926 |
| 126 | Lysosome_Homo sapiens_hsa04142 | 0.45288779 |
| 127 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.45186296 |
| 128 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.44283690 |
| 129 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.36283742 |
| 130 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34559206 |
| 131 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.32082670 |
| 132 | Metabolic pathways_Homo sapiens_hsa01100 | 0.31655752 |
| 133 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.26921139 |
| 134 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.22438933 |
| 135 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.21605893 |

